On this page

Changing flow rather than filling the sac

A flow-diverting implant is placed in the parent artery across the aneurysm opening. Its mesh changes the flow entering the sac and provides a surface along which healing can develop. Closure may progress over time rather than occurring immediately at implantation. A technically successful placement therefore does not establish that the aneurysm is already fully excluded from circulation. Imaging follow-up matters.1

Flow diversion is one option for selected anatomy. The parent artery, branches, shape and neck, rupture status and procedural risks all affect suitability. It is not a universally safer replacement for clipping or coiling. The 2022 ESO unruptured guideline takes a cautious approach to flow-diverting stents when other lower-risk repair options are unavailable; its recommendations have very low-certainty evidence and require individualized discussion.2

Ruptured aneurysms require a separate decision

Acute rupture presents an immediate rebleeding problem. Delayed closure and the implications of a parent-artery implant can make flow diversion particularly complex in that situation. The 2026 European guideline's expert consensus reserves it as a last-line option when alternatives are unsuitable. That is different from the evidence-based regular-coiling recommendation for selected aSAH patients. Outcomes from elective unruptured cohorts should not be transferred to an acute hemorrhage.3

What PREMIER contributes

PREMIER was a prospective, single-arm study of 141 patients with selected unruptured wide-neck aneurysms no larger than 12 mm in specified internal carotid or vertebral segments. It used historical Pipeline Classic/Flex devices and had no randomized comparison with other approaches. At three years, the reported complete-closure denominator was 138, and later imaging was chiefly required for lesions incompletely closed at one year. Some missing later observations were carried forward.1

Closure, the composite effectiveness endpoint, major neurological events, retreatment and functional independence were separate measurements. The study recorded harms as well as anatomical outcomes, and industry funding and selected eligibility limit generalization. It does not establish comparative superiority for every model or every aneurysm.1

Medication, imaging and continuity of care

Parent-artery implants require specialist planning about thrombosis, bleeding and medicines affecting platelet activity. The study protocol is not a prescription for another patient.1

Ask what remains to be assessed after implantation, which imaging is planned and what persistent filling or narrowing would mean. Keep the exact device record for future clinicians and imaging services. MRI conditions depend on that specific implant and the imaging service's assessment; there is no category-wide clearance here.

If a device is proposed, ask the responsible specialist to confirm current exact-model information, alternatives and follow-up arrangements. Travellers also need a named clinician at home and a plan for exchanging images and managing later problems.

References

  1. Hanel RA et al. PREMIER study: 3-year results with a flow diverter specific occlusion classification. Journal of NeuroInterventional Surgery. 2023;15:248–254 (online 2022). doi:10.1136/neurintsurg-2021-018501. Source ↩
  2. Etminan N et al. European Stroke Journal. 2022;7: LXXXI–CVI. doi:10.1177/23969873221099736. Source ↩
  3. Vergouwen MDI et al. European Stroke Journal. 2026;11(5):aakag043. doi:10.1093/esj/aakag043. Source ↩